AVC-S-101

N/A

Report date: 2026/04/15 20:02:38

Base Information

Drug NameAVC-S-101
Drug Alias NameAVC-S-101
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionAnti-Trop-2
TargetsTumor-associated calcium signal transducer 2
Therapy Area/IndicationsUrinary Bladder NeoplasmsSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvidicure BV
China Registration ClassN/A

Develop Information

Active CompaniesAvidicure BV
Inactive CompaniesN/A
Active IndicationsUrinary Bladder NeoplasmsSmall Cell Lung CarcinomaCarcinoma, Non-Small-Cell Lung +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A